World A Step Closer To First Human Plasmid DNA Vaccine As Zydus Seeks EUA
COVID-19 Candidate Effective Against Delta Variant
A plasmid DNA vaccine for human use has moved a step closer to reality, with Zydus Cadila applying for an accelerated nod for its COVID-19 candidate in India. 67% efficacy reported in an interim data readout and Delta variant being the prominent strain during a Phase III trial imply better odds for approval.
